Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer

1 Jan 2021

Abstract excerpt

Despite the steadily increasing worldwide incidence of colorectal cancer (CRC), an effective noninvasive approach for early detection of CRC is still under investigation. The guaiac-based fecal occult blood test (FOBT) and fecal immunochemical test (FIT) have gained popularity as noninvasive CRC screening tests owing to their convenience and relatively low costs. However, the FOBT and FIT have limited sensitivity...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Screening and Detection
Share to Gastric Cancer Management and Outcomes
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33393623
DOI: 10.1042/bsr20201930

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancerPMID 33393623Read ↗

Stool DNA Test of Methylated Syndecan-2 for the Early Detection of Colorectal NeoplasiaSemantic proximity Read ↗

A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNASemantic proximity Read ↗

A Stool DNA-Based SDC2 Methylation Test for the Early Detection of Colorectal Cancer in an Asymptomatic, High-Risk Population: A Multicenter Prospective Randomized TrialSemantic proximity Read ↗

Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNASemantic proximity Read ↗

Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancerSemantic proximity Read ↗

Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early DetectionSemantic proximity Read ↗

The Roadmap of Colorectal Cancer ScreeningSemantic proximity Read ↗

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal CancerSemantic proximity Read ↗

Biomarkers for Early Detection of Colorectal Cancer: The Early Detection Research Network, a Framework for Clinical TranslationSemantic proximity Read ↗

Evaluating the Clinical Performance of SDC2/NDRG4 Methylation for Colorectal Cancer DetectionSemantic proximity Read ↗

Molecular tests for colorectal cancer screening.Semantic proximity Read ↗

Evaluating the Clinical Performance of a Dual-Target Stool DNA Test for Colorectal Cancer DetectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.